Search

A recent study conducted by researchers at Alma Mater Studiorum-University of Bologna in Italy has focused on the use of carboranes in boron neutron capture therapy (BNCT) for cancer treatment. Carboranes have shown promise as effective boron agents in BNCT. The study examined the in vivo application of carboranes, including their biodistribution, pharmacokinetics, and pharmacodynamics. The researchers aimed to identify the strengths and weaknesses of carboranes in BNCT and determine the best strategies for future applications. This research provides valuable insights into the potential of carboranes in cancer gene therapy. [Extracted from the article]